Sichuan Goldstone Asia Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Sichuan Goldstone Asia Pharmaceutical has a total shareholder equity of CN¥2.5B and total debt of CN¥115.9M, which brings its debt-to-equity ratio to 4.6%. Its total assets and total liabilities are CN¥3.1B and CN¥591.8M respectively. Sichuan Goldstone Asia Pharmaceutical's EBIT is CN¥177.4M making its interest coverage ratio -30.9. It has cash and short-term investments of CN¥466.3M.
Key information
4.6%
Debt to equity ratio
CN¥115.92m
Debt
Interest coverage ratio | -30.9x |
Cash | CN¥466.27m |
Equity | CN¥2.51b |
Total liabilities | CN¥591.79m |
Total assets | CN¥3.11b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300434's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥517.9M).
Long Term Liabilities: 300434's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥73.9M).
Debt to Equity History and Analysis
Debt Level: 300434 has more cash than its total debt.
Reducing Debt: 300434's debt to equity ratio has increased from 0.9% to 4.6% over the past 5 years.
Debt Coverage: 300434's debt is well covered by operating cash flow (102.1%).
Interest Coverage: 300434 earns more interest than it pays, so coverage of interest payments is not a concern.